Age-dependent differences in sensitivity and sensitization to cannabinoids and 'club drugs' in male adolescent and adult rats.
Jenny L Wiley, Rhys L Evans, Darren B Grainger, Katherine L Nicholson
Addiction Biology September 2008 DOI: 10.1111/j.1369-1600.2007.00077.x (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Preclinical experimental study Peer reviewed |
|---|---|
| Population | Adolescent and adult male rats |
| Interventions | Cocaine Delta(9)-tetrahydrocannabinol (Delta(9)-THC) Ketamine 3 4-methylenedioxymethamphetamine (MDMA) |
| Duration | Two 5-day dosing periods separated by a 2-day drug holiday; 20-minute locomotor sessions after each injection |
| Key findings | Cocaine, ketamine, and MDMA produced less motor stimulation in adolescent male rats than in adult males, and repeated ketamine dosing produced sensitization in adults but not adolescents. Adolescents were initially more sensitive to low-dose Delta(9)-THC stimulation, but tolerance developed rapidly. The authors suggest this differential sensitivity may contribute to different patterns of use in adolescent versus adult drug abusers. |
Abstract
Lifelong substance abuse is often initiated during adolescence; yet, most pre-clinical research in this area has been conducted in adult animals. Substantial evidence exists that the brain development that continues throughout adolescence may result in pharmacological responses that differ in a crucial manner from those of adults. The goal of this study was to evaluate age differences in motor activity following acute and repeated administration of drugs that are commonly abused by adolescents, including cocaine, Delta(9)-tetrahydrocannabinol (Delta(9)-THC), and the club drugs, ketamine and 3,4-methylenedioxymethamphetamine (MDMA). Adolescent and adult male rats were injected once daily with saline or with a dose of one of the test drugs for two 5-day dosing periods, separated by a 2-day drug holiday during which they remained in their home cages. Following each injection, rats were placed in a locomotor chamber for a 20-minute session. The potencies of cocaine, ketamine and MDMA for producing motor stimulation were less in male adolescents than in male adults. Furthermore, sensitization to the club drug, ketamine, developed after repeated dosing in adults, but not adolescents. In contrast, adolescents were initially more sensitive to the stimulatory effects of low doses of Delta(9)-THC than were adults, although rapid tolerance occurred. These results suggest that adolescents are less sensitive to the acute and repeated stimulant effects of some, but not all, of the drugs that are preferentially abused by this age group. This differential sensitivity may contribute to the different patterns of use that have been noted in adolescent versus adult drug abusers.
Citations in the library
Cited by 20
- Ketamine use: a review Addiction July 21, 2011
- The abuse liability of ketamine: A scoping review of preclinical and clinical studies. Journal of Psychiatric Research May 1, 2022
- On the safety of repeated ketamine infusions for the treatment of depression: Effects of sex and developmental periods Neurobiology of Stress September 21, 2018
- Use and abuse of dissociative and psychedelic drugs in adolescence Pharmacology, Biochemistry, and Behavior January 27, 2021
- PRECLINICAL STUDY: Acquisition and reinstatement of MDMA‐induced conditioned place preference in mice pre‐treated with MDMA or cocaine during adolescence Addiction Biology September 8, 2009
and 15 more in the library
Cites 4
- Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans Archives of General Psychiatry March 1, 1994
- Chemistry, Pharmacology, Toxicology, and Hepatic Metabolism of Designer Drugs of the Amphetamine (Ecstasy), Piperazine, and Pyrrolidinophenone Types Therapeutic Drug Monitoring March 19, 2004
- Role of the NMDA receptor subunit in the expression of the discriminative stimulus effect induced by ketamine. European Journal of Pharmacology June 29, 2001
- Age modulates the long-term but not the acute effects of the serotonergic neurotoxicant 3,4-methylenedioxymethamphetamine. Journal of Pharmacology and Experimental Therapeutics October 1, 1994